Target intelligence / Profile preview

Prefoldin subunit 1 pseudogene 2 (PFDN1P2)

Target
PFDN1P2
Molecular classification
Other (Pseudogene)
01

Overview

PFDN1 pseudogene 2 (PFDN1P2) is a pseudogene related to prefoldin subunit 1, a member of the prefoldin family of molecular chaperones. Unlike its parent gene (PFDN1), which codes for a component of the hexameric prefoldin complex involved in protein folding, PFDN1P2 does not produce a functional protein product. There is currently no evidence of biological activity, protein-coding capability, or disease relevance for PFDN1P2. It is not considered a therapeutic target, receptor, enzyme, or biomarker, and is not associated with drug interactions, mechanisms of action, or safety concerns. The functional prefoldin complex is important for maintaining protein homeostasis, cytoskeletal assembly, and is implicated in various cancers[1][3][5]. However, none of these roles are attributed to the PFDN1 pseudogene 2. If you intended information about the functional protein PFDN1 or PFDN2, rather than the pseudogene, please clarify, as those are molecular chaperones with disease roles, molecular interactions, and possible targeting relevance[3][5].

Other names
PFDN1 pseudogene 2prefoldin subunit 1 pseudogene, PFDN1P2PFDN1P2
02

Mechanism of action

There are no mechanisms of action relevant to PFDN1P2 from a pharmacological standpoint.

03

Biological functions

PFDN1P2 does not have known biological functions as it does not produce a functional protein. In general, pseudogenes may have regulatory roles at the RNA level, but no evidence for such function is available for PFDN1P2 in current literature[1][3][5].
04

Disease associations

Unlike the protein-coding PFDN1 gene, whose overexpression is implicated in cancer progression and cytoskeletal dysfunction[3][5], PFDN1P2 as a pseudogene has not been linked to disease states.
05

Safety considerations

As a non-coding pseudogene, PFDN1P2 does not present relevant therapeutic challenges[1][3][5].
06

Interacting drugs

There are no drugs known to interact with PFDN1P2.
07

Biomarkers

None reported.

Beyond the preview

Go deeper on Prefoldin subunit 1 pseudogene 2 (PFDN1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prefoldin subunit 1 pseudogene 2 (PFDN1P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call